scholarly article | Q13442814 |
P50 | author | Louise Turner | Q43240630 |
Thor G. Theander | Q54802168 | ||
Lars Hviid | Q55174838 | ||
Thomas Lavstsen | Q80377133 | ||
Martha M Lemnge | Q87131272 | ||
John Lusingu | Q90228924 | ||
Lasse S Vestergaard | Q114320005 | ||
Pamela Magistrado | Q114320963 | ||
P2093 | author name string | Anja T R Jensen | |
P2860 | cites work | Genome sequence of the human malaria parasite Plasmodium falciparum | Q22122524 |
The var genes of Plasmodium falciparum are located in the subtelomeric region of most chromosomes | Q24562131 | ||
Malaria morbidity and immunity among residents of villages with different Plasmodium falciparum transmission intensity in North-Eastern Tanzania | Q24800714 | ||
Expression of Plasmodium falciparum erythrocyte membrane protein 1 in experimentally infected humans | Q24804115 | ||
Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions | Q24804747 | ||
Plasmodium falciparum variant surface antigen expression patterns during malaria | Q24811060 | ||
Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria | Q27976511 | ||
Immunity to non-cerebral severe malaria is acquired after one or two infections | Q28139257 | ||
The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes | Q29393314 | ||
Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes | Q29618254 | ||
Transcription of multiple var genes by individual, trophozoite-stage Plasmodium falciparum cells expressing a chondroitin sulphate A binding phenotype | Q30828703 | ||
Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigens | Q31064176 | ||
Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines | Q33617104 | ||
Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria | Q33890328 | ||
Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. | Q34000292 | ||
Antibodies to variant antigens on the surfaces of infected erythrocytes are associated with protection from malaria in Ghanaian children. | Q34007707 | ||
Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line | Q34020876 | ||
Antigenic variation at the infected red cell surface in malaria. | Q34360835 | ||
Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes | Q34601747 | ||
Lack of gender-specific antibody recognition of products from domains of a var gene implicated in pregnancy-associated Plasmodium falciparum malaria | Q35106301 | ||
Limited cross-reactivity among domains of the Plasmodium falciparum clone 3D7 erythrocyte membrane protein 1 family | Q35220304 | ||
Malaria immunity in infants: a special case of a general phenomenon? | Q35640581 | ||
Association of severe noncerebral Plasmodium falciparum malaria in Brazil with expressed PfEMP1 DBL1 alpha sequences lacking cysteine residues | Q36087903 | ||
Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes | Q36399515 | ||
Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. | Q37331646 | ||
Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. | Q37659330 | ||
Multiple var gene transcripts are expressed in Plasmodium falciparum infected erythrocytes selected for adhesion. | Q38300351 | ||
Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa | Q39115032 | ||
Plasmodium falciparum infections are associated with agglutinating antibodies to parasite-infected erythrocyte surface antigens among healthy Kenyan children | Q39123150 | ||
Low antibody responses to variant surface antigens of Plasmodium falciparum are associated with severe malaria and increased susceptibility to malaria attacks in Gabonese children. | Q39515251 | ||
Malaria-induced acquisition of antibodies to plasmodium falciparum variant surface antigens | Q39655161 | ||
Plasmodium falciparum rosetting is associated with malaria severity in Kenya | Q39822248 | ||
Expression of var genes located within polymorphic subtelomeric domains of Plasmodium falciparum chromosomes. | Q40022566 | ||
Criteria for diagnosing clinical malaria among a semi-immune population exposed to intense and perennial transmission | Q40821519 | ||
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies | Q41175606 | ||
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection | Q44147641 | ||
Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction | Q44161485 | ||
In vitro selection of Plasmodium falciparum 3D7 for expression of variant surface antigens associated with severe malaria in African children | Q44691470 | ||
CD36 peptides that block cytoadherence define the CD36 binding region for Plasmodium falciparum-infected erythrocytes. | Q44951127 | ||
Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections | Q46184700 | ||
Identification of a conserved Plasmodium falciparum var gene implicated in malaria in pregnancy | Q46586152 | ||
Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age. | Q46809348 | ||
Developmental selection of var gene expression in Plasmodium falciparum | Q47741507 | ||
A study of var gene transcription in vitro using universal var gene primers | Q47857241 | ||
Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity | Q47901577 | ||
Expression of Plasmodium falciparum-infected erythrocyte membrane protein from cerebral malaria patients. | Q47921891 | ||
Evidence for the importance of genetic structuring to the structural and functional specialization of the Plasmodium falciparum var gene family | Q47971150 | ||
Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections | Q47997112 | ||
A var gene promoter controls allelic exclusion of virulence genes in Plasmodium falciparum malaria | Q48021609 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | malaria | Q12156 |
Plasmodium falciparum | Q311383 | ||
membrane protein | Q423042 | ||
P304 | page(s) | 2415-2420 | |
P577 | publication date | 2007-02-05 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Immunoglobulin G antibody reactivity to a group A Plasmodium falciparum erythrocyte membrane protein 1 and protection from P. falciparum malaria | |
P478 | volume | 75 |
Q33340826 | A method for visualizing surface-exposed and internal PfEMP1 adhesion antigens in Plasmodium falciparum infected erythrocytes |
Q34147732 | A plasma survey using 38 PfEMP1 domains reveals frequent recognition of the Plasmodium falciparum antigen VAR2CSA among young Tanzanian children |
Q36810422 | ARAM: an automated image analysis software to determine rosetting parameters and parasitaemia in Plasmodium samples |
Q24651173 | Acquired immunity to malaria |
Q41813370 | Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1. |
Q33813188 | Allelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes |
Q36689554 | Analysis of antibody induction upon immunization with distinct NTS-DBL1α-domains of PfEMP1 from rosetting Plasmodium falciparum parasites |
Q34103586 | Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers |
Q38625368 | Antigenic Variation in Plasmodium falciparum |
Q24672872 | Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene family |
Q35865612 | Changes in var gene mRNA levels during erythrocytic development in two phenotypically distinct Plasmodium falciparum parasites |
Q64115691 | Comprehensive analysis of Fc-mediated IgM binding to the Plasmodium falciparum erythrocyte membrane protein 1 family in three parasite clones |
Q91820560 | Comprehensive analysis of antibody responses to Plasmodium falciparum erythrocyte membrane protein 1 domains |
Q36009883 | Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria |
Q36124623 | Evidence for in vitro and in vivo expression of the conserved VAR3 (type 3) plasmodium falciparum erythrocyte membrane protein 1. |
Q34290645 | Hierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children |
Q33432676 | High throughput functional assays of the variant antigen PfEMP1 reveal a single domain in the 3D7 Plasmodium falciparum genome that binds ICAM1 with high affinity and is targeted by naturally acquired neutralizing antibodies |
Q36071842 | Mapping the Binding Site of a Cross-Reactive Plasmodium falciparum PfEMP1 Monoclonal Antibody Inhibitory of ICAM-1 Binding. |
Q44383434 | PfEMP1 as a target of human immunity and a vaccine candidate against malaria |
Q33700519 | Plasmodium falciparum erythrocyte membrane protein 1 diversity in seven genomes--divide and conquer |
Q34853037 | Plasmodium falciparum expressing domain cassette 5 type PfEMP1 (DC5-PfEMP1) bind PECAM1. |
Q36888526 | Serological Conservation of Parasite-Infected Erythrocytes Predicts Plasmodium falciparum Erythrocyte Membrane Protein 1 Gene Expression but Not Severity of Childhood Malaria |
Q34161839 | Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates |
Q27313623 | Surface co-expression of two different PfEMP1 antigens on single plasmodium falciparum-infected erythrocytes facilitates binding to ICAM1 and PECAM1 |
Q34221833 | The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children |
Q33846617 | The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs |
Q28070246 | The role of PfEMP1 as targets of naturally acquired immunity to childhood malaria: prospects for a vaccine |
Search more.